Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Xeris Pharmaceuticals and OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon

Saturday, August 18, 2018

Xeris Pharmaceuticals Inc a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize readytouse injectable and infusible drug formulations announced today that Jessica Castle MD an associate professor of...

AgeX Therapeutics Acquires Technology to Regulate Immune Tolerance

Friday, August 17, 2018

AgeX Therapeutics Inc a subsidiary of BioTime Inc focused on the development and commercialization of novel therapeutics targeting human aging today announced that it has acquired certain patents and patent applications from Escape Therapeutics relat...

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

Friday, August 17, 2018

BioNTech AG a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease today announced that it has entered into a multiyear research and development RD collaboration with Pfizer Inc t...

Stealth BioTherapeutics Expands Pipeline, Advances New Compound

Thursday, August 16, 2018

Stealth BioTherapeutics Stealth a clinicalstage biopharmaceutical company developing a firstinclass platform of novel therapeutic compounds for the treatment of diseases associated with mitochondrial dysfunction announced today that it is advancing a...

Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome

Thursday, August 16, 2018

Biopharmaceutical company Emalex Biosciences Emalex the newest member of the Paragon Biosciences Paragon portfolio of companies today announced it acquired Psyadon Pharmaceuticals and the exclusive rights to develop register and market ecopipam a new...

Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt

Tuesday, August 14, 2018

Cancer Prevention Pharmaceuticals Inc CPP a private biotech company developing novel therapeutics to prevent cancer and other diseases announced the signing of a license agreement with Mallinckrodt Pharmaceuticals through its Sucampo AG subsidiary Ma...

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

Tuesday, August 14, 2018

Medicure Inc a cardiovascular pharmaceutical company is pleased to announce that the United States Food and Drug Administration FDA has approved its Abbreviated New Drug Application ANDA for Sodium Nitroprusside Injection mg mL mgmL single dose via...

Astellas announces acquisition of Quethera

Monday, August 13, 2018

Astellas Pharma Inc and Quethera Limited announced today that Astellas has acquired Quethera a UKbased gene therapy company focused on the development of novel eye care treatments such as glaucoma Through this transaction Astellas has acquired Que...

OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company

Friday, August 10, 2018

OvaScienceSM and privatelyheld Millendo Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases announced today that they have entered into a definitive agreement under which Ova...

JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

Friday, August 10, 2018

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA related to the EU approval pathway for its proposed bevacizumab biosimilar JHL to tre...